J&J suspends sales forecast for COVID-19 vaccine, cuts profit view
Johnson & Johnson on Tuesday suspended its sales forecast for COVID-19 vaccine due to global supply surplus and demand uncertainty and cut its adjusted profit expectation, sending the drugmaker's shares down nearly 3%.